Veronique Marie Andre

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Agonists at dopamine D2 and D3 receptors are important therapeutic agents in the treatment of Parkinson's disease. Compared with the use of agonists, allosteric potentiators offer potential advantages such as temporal, regional, and phasic potentiation of natural signaling, and that of receptor subtype selectivity. We report the identification of a(More)
  • 1